Some consumer health advocates and pharmacists are concerned that the FDA and the FTC aren’t doing enough to monitor where more and more people see ads.
Top government health officials are calling for new research into the feasibility of deploying test strips that quickly and accurately identify fentanyl and other dangerous substances like xylazine.